Skip to NavigationSkip to content

Stephen Stamp joins board at Eusa Pharma

Published on: 07/09/10

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director.

Stephen has previously held board-level roles at Xanodyne Pharmaceuticals and Shire Pharmaceuticals, and was most recently chief financial officer at K-V Pharmaceutical Company.

Commenting on his appointment, Stephen said, “Having witnessed EUSA’s impressive growth, I am excited to be helping the company achieve its ambitious plans.

“Having already built a robust commercial infrastructure in the US and Europe, and a wider global distribution network, I believe EUSA is well placed for future success, and I welcome the opportunity to be part of the company’s continued rapid development.”

Eusa is jointly based in Oxford, UK and Langhorne, PA, in the US and focuses on in-licensing, developing and marketing late-stage oncology, pain control and critical care products.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches